| Synovo uses a full spectrum of technologies to synthesise, screen, optimise and characterise drug candidates
Core Synovo technologies include:
By combining these approaches in one company there is very rapid interchange of information surrounding compounds that allows highly directed synthesis. Through this approach, Synovo can achieve an adequate early understanding of drug activity and efficiently prioritise optimisation concepts based on timely data. |
|||